KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:DRNA
Delisted

Dicerna Pharmaceuticals Stock Price (Quote)

$38.22
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $38.22 $38.22 Friday, 27th May 2022 DRNA stock ended at $38.22. During the day the stock fluctuated 0% from a day low at $38.22 to a day high of $38.22.
90 days $38.22 $38.22
52 weeks $19.06 $40.14

Historical Dicerna Pharmaceuticals prices

Date Open High Low Close Volume
Aug 12, 2021 $21.50 $21.56 $20.56 $20.78 1 421 026
Aug 11, 2021 $22.25 $22.50 $20.92 $21.29 2 298 522
Aug 10, 2021 $23.84 $23.98 $21.56 $22.19 2 116 023
Aug 09, 2021 $26.94 $27.78 $23.65 $23.83 3 428 854
Aug 06, 2021 $26.37 $28.15 $24.00 $27.25 6 448 664
Aug 05, 2021 $37.35 $38.04 $36.97 $37.92 478 994
Aug 04, 2021 $36.97 $37.95 $35.86 $37.30 372 548
Aug 03, 2021 $37.00 $37.29 $35.89 $36.90 499 470
Aug 02, 2021 $37.93 $37.93 $36.89 $36.94 377 335
Jul 30, 2021 $37.10 $37.92 $37.10 $37.51 406 966
Jul 29, 2021 $37.31 $38.31 $36.88 $37.15 335 791
Jul 28, 2021 $37.12 $37.91 $36.55 $37.30 492 789
Jul 27, 2021 $36.94 $37.00 $35.19 $36.90 747 817
Jul 26, 2021 $37.64 $38.70 $36.85 $36.97 288 054
Jul 23, 2021 $37.86 $38.26 $36.29 $37.51 664 878
Jul 22, 2021 $38.48 $38.72 $37.75 $37.88 560 898
Jul 21, 2021 $39.71 $39.71 $37.19 $38.50 1 031 961
Jul 20, 2021 $38.84 $40.14 $38.65 $39.99 926 580
Jul 19, 2021 $37.56 $38.96 $37.43 $38.41 781 182
Jul 16, 2021 $36.98 $38.95 $36.92 $38.00 732 775
Jul 15, 2021 $39.00 $39.09 $36.32 $36.82 843 354
Jul 14, 2021 $37.88 $39.58 $37.37 $38.88 802 545
Jul 13, 2021 $38.67 $38.93 $37.19 $37.52 480 605
Jul 12, 2021 $38.11 $39.56 $37.68 $39.05 1 550 414
Jul 09, 2021 $38.22 $38.93 $37.27 $38.04 472 513
Click to get the best stock tips daily for free!

About Dicerna Pharmaceuticals

Dicerna Pharmaceuticals Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of treatments for liver diseases and cancers based on a proprietary RNA interference technology platform in the United States and internationally. The company’s development programs include DCR-PH1 for the treatment of primary hyperoxaluria type 1 (PH1) through targeting the gene encoding the liver enzyme glycolate oxidase; and other rare inherit... DRNA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT